Back to Screener

Healthcare

Gossamer Bio, Inc.(GOSS)

Live Price

Offline

$0.1614

-4.50% today

1Y Change

-87.08%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$80.00M
Revenue Growth
-57.7%
EPS Growth
-200.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Gossamer Bio, Inc. (GOSS) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $0.16 and down 87.1% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of -57.7%, EPS growth of -200.0%, a dividend yield of 0.0%. What stands out right now is revenue -57.7%, EPS -200.0%, free cash flow -4840.7% with operating margin -352.2% and ROIC -155.5%. Valuation is more restrained than many high-expectation growth names at price/sales 1.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GOSS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GOSS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GOSS

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

GOSS Max Drawdown

-95.88%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GOSS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 21, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 21, 26
โ€”
Est -0.18
โ€”
โ€”
Est 4605.9B
โ€”
May 21
โ€”
Mar 17, 26
โœ—
-0.21
Est -0.20
-5.0%
13799.0B
Est 7522.3B
+83.4%
Mar 17
โ€”
Nov 5, 25
โœ—
-0.21
Est -0.19
-10.5%
13294.0B
Est 7526.3B
+76.6%
Nov 5
โ€”
Aug 5, 25
โœ“
-0.17
Est -0.18
+5.6%
11489.0B
Est 5408.8B
+112.4%
Aug 5
โ€”
May 15, 25
โœ“
-0.16
Est -0.18
+11.1%
9889.0B
Est 3947.3B
+150.5%
May 15
โ€”
Mar 13, 25
โœ“
-0.15
Est -0.17
+11.8%
9379.0B
Est 6834.3B
+37.2%
Mar 13
โ€”
Nov 7, 24
โœ“
-0.14
Est -0.18
+22.2%
9480.0B
Est 6834.3B
+38.7%
Nov 7
โ€”
Aug 12, 24
โœ—
0.22
Est 0.23
-4.3%
95842.0B
Est 114290.0B
-16.1%
Aug 12
โ€”
May 7, 24
โ€”
-0.19
Est -0.19
0.0%
โ€”
Est โ€”
โ€”
May 7
โ€”
Mar 5, 24
โœ—
-0.21
Est -0.20
-5.0%
6784.0B
Est โ€”
โ€”
Mar 5
โ€”
Nov 9, 23
โœ—
-0.21
Est -0.20
-5.0%
โ€”
Est โ€”
โ€”
Nov 9
โ€”
Aug 8, 23
โœ“
-0.45
Est -0.49
+8.2%
โ€”
Est โ€”
โ€”
Aug 8
โ€”
May 9, 23
โœ“
-0.52
Est -0.55
+5.5%
โ€”
Est โ€”
โ€”
May 9
โ€”
Mar 17, 23
โœ“
-0.59
Est -0.62
+4.8%
โ€”
Est โ€”
โ€”
Mar 17
โ€”
Nov 3, 22
โœ“
-0.65
Est -0.66
+1.5%
โ€”
Est โ€”
โ€”
Nov 3
โ€”
Aug 9, 22
โœ—
-0.74
Est -0.67
-10.4%
โ€”
Est โ€”
โ€”
Aug 9
โ€”
May 10, 22
โœ“
-0.76
Est -0.77
+1.3%
โ€”
Est โ€”
โ€”
May 10
โ€”
Mar 3, 22
โ€”
-0.74
Est -0.74
0.0%
โ€”
Est โ€”
โ€”
Mar 3
โ€”
Nov 8, 21
โœ—
-0.80
Est -0.78
-2.6%
โ€”
Est โ€”
โ€”
Nov 8
โ€”
Aug 9, 21
โœ—
-0.80
Est -0.77
-3.9%
โ€”
Est โ€”
โ€”
Aug 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener